OM-85 BV (Broncho-Vaxom) — Competitive Intelligence Brief

OM-85 BV (Broncho-Vaxom) (OM-85 BV (Broncho-Vaxom)) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bacterial lysate immunostimulant. Area: Immunology / Respiratory.

marketed Bacterial lysate immunostimulant Immunology / Respiratory Small molecule

Target snapshot

OM-85 BV (Broncho-Vaxom) (OM-85 BV (Broncho-Vaxom)) — Kecioren Education and Training Hospital. OM-85 BV is an immunostimulant derived from bacterial lysates that enhances innate and adaptive immune responses to reduce respiratory tract infections.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
OM-85 BV (Broncho-Vaxom) TARGET	OM-85 BV (Broncho-Vaxom)	Kecioren Education and Training Hospital	marketed	Bacterial lysate immunostimulant
OM-85 BV	OM-85 BV	Chinese Academy of Medical Sciences	marketed	Bacterial lysate immunostimulant
Broncho-Vaxom	Broncho-Vaxom	OM Pharma SA	phase 3	Bacterial lysate immunostimulant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bacterial lysate immunostimulant class)

1. Chinese Academy of Medical Sciences · 1 drug in this class
2. Kecioren Education and Training Hospital · 1 drug in this class
3. OM Pharma SA · 1 drug in this class